[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557000":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":27,"responsibleParty":43,"collaborators":45,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"GCS Ramsay Santé pour l'Enseignement et la Recherche","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"cohort of outpatients",null,"Adult patients diagnosed with localised kidney cancer, undergoing scheduled surgery for partial or total laparoscopic nephrectomy on an outpatient basis.",[13],"Procedure: Partial or total laparoscopic nephrectomy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Partial or total laparoscopic nephrectomy","Nephrectomy is currently the primary indication for localised kidney cancer. All patients consulting a surgeon at the Clinique de la Sauvegarde for localised kidney cancer, for which surgical excision has been validated by the multidisciplinary consultation meeting and who are eligible for outpatient treatment, will be offered the opportunity to take part in this study during the preoperative consultation.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Arnaud MD BALDINI","CONTACT","469001019","+33","docteur.baldini@urolyon-ouest.fr",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Clinique de la Sauvegarde","RECRUITING","Lyon","69009","France","FR",{"type":36,"coordinates":37},"Point",[38,39],4.84789,45.74906,{"lat":39,"lon":38},[42],{"name":22,"role":23,"phone":10,"phoneExt":10,"email":26},{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46],{"name":47,"class":48},"Euraxi Pharma","INDUSTRY","100557000","study-of-post-operative-complications-after-laparoscopic-outpatient-nephrectomy-100557000",false,"NCT06532422","Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy","Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy in Patients With Localised Kidney Cancer","NEPHRAMBU","Inclusion Criteria:\n\n* Patients over 18 ;\n* Localised kidney cancer ;\n* Validation of curative treatment at a multidisciplinary consultation meeting;\n* Partial or total laparoscopic nephrectomy scheduled on an outpatient basis;\n* Membership of a social security scheme or receiving State Medical Aid;\n* Patient able to understand the information relating to the study, to read the information leaflet and who has given his\u002Fher oral non-objection.\n\nExclusion Criteria:\n\n* Emergency intervention ;\n* Patient not eligible for outpatient treatment;\n* Long-term curative anti-coagulant treatment ;\n* Resident more than 100km from the clinic;\n* Home alone on the first night;\n* Patient of protected age (under guardianship or curatorship, or deprived of liberty).","ALL","18 Years",{"count":60,"type":61},50,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to compare to assess the incidence of post-operative complications related to nephrectomy, which occur up to 1 month after the operation.",[65],"Kidney Cancer","2026-03-27",{"date":68,"type":69},"2026-04-01","ACTUAL",{"date":71,"type":69},"2024-12-13",{"date":73,"type":61},"2026-09",{"name":5,"class":6},1]